Global antibiotic overuse in infant care: How colonial medical legacies and profit-driven diagnostics obscure equitable pediatric health solutions
Original framing: “Blood test could gauge if a baby has a dangerous infection in 15 minutes” — New Scientist
The roots of antibiotic overuse in infant care trace to 19th-century colonial hospitals, where European doctors dismissed local healing practices as ‘primitive’ and prescribed antibiotics to ‘civilize’ populations. This legacy persists today: in 1950s India, British-trained pediatricians introduced mass antibiotic use in rural clinics, creating resistance hotspots that now threaten Global South children. The *New Scientist*’s framing erases this history, presenting the test as a neutral innovation rather than a tool that could perpetuate colonial-era health inequities if deployed without cultural or historical awareness.
The *New Scientist* headline masks a systemic paradox: a ‘solution’ to antibiotic overuse is being sold as a neutral innovation while perpetuating the very structures that created the crisis.
Colonial medicine’s erasure of Indigenous diagnostic systems—from *African* pulse-reading to *Andean* herbalism—left Global South infants vulnerable to both untreated viral infections *and* antibiotic resistance, a legacy now exploited by patented tests. The trickster here is capitalism’s co-optation of urgency: the test’s speed distracts from the need for reparative justice, like funding Indigenous-led health sovereignty or open-sourcing diagnostics. Historical precedents (e.g., *Maathai’s* Green Belt Movement) show that community-centered, culturally adapted care—not rapid lab tests—has consistently reduced infant mortality. The path forward demands dismantling diagnostic colonialism: replacing patented tools with decolonized, hybrid systems that honor traditional knowledge while leveraging modern science, all funded by reparations for centuries of health exploitation.